During the past decade, Prisma Health Cancer Institute - Eastside conducted 207 clinical trials. In the 10-year time frame, 207 clinical trials started and 174 clinical trials were completed, i.e. on average, 84.1% percent of trials that started reached the finish line to date. In the past 5 years, 65 clinical trials started and 106 clinical trials were completed. i.e. 163.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prisma Health Cancer Institute - Eastside" #1 sponsor was "National Cancer Institute (NCI)" with 126 trials, followed by "SWOG Cancer Research Network" with 49 trials sponsored, "Children's Oncology Group" with 48 trials sponsored, "Alliance for Clinical Trials in Oncology" with 45 trials sponsored and "NRG Oncology" with 45 trials sponsored. Other sponsors include 85 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prisma Health Cancer Institute - Eastside" #1 collaborator was "National Cancer Institute (NCI)" with 212 trials as a collaborator, "NRG Oncology" with 33 trials as a collaborator, "Canadian Cancer Trials Group" with 12 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator and "Radiation Therapy Oncology Group" with 5 trials as a collaborator. Other collaborators include 68 different institutions and companies that were collaborators in the rest 59 trials.

According to Clinical.Site data, the most researched conditions in "Prisma Health Cancer Institute - Eastside" are "Breast Cancer" (15 trials), "Acute Lymphoblastic Leukemia" (11 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Lung Cancer" (8 trials) and "Recurrent Ovarian Carcinoma" (8 trials). Many other conditions were trialed in "Prisma Health Cancer Institute - Eastside" in a lesser frequency.

Most popular intervention types in "Prisma Health Cancer Institute - Eastside" are "Drug" (283 trials), "Other" (235 trials), "Biological" (117 trials), "Radiation" (81 trials) and "Procedure" (79 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (121 trials), "Quality-of-Life Assessment" (80 trials), "Questionnaire Administration" (56 trials), "Cisplatin" (40 trials) and "Carboplatin" (34 trials). Other intervention names were less common.

The vast majority of trials in "Prisma Health Cancer Institute - Eastside" are 305 trials for "All" genders, 57 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are NaN active trials in "Prisma Health Cancer Institute - Eastside". undefined are not yet recruiting, 70 are recruiting, 156 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 118 completed trials in Prisma Health Cancer Institute - Eastside, 8 suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Prisma Health Cancer Institute - Eastside, 13 "Phase 1" clinical trials were conducted, 149 "Phase 2" clinical trials and 192 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 17 trials that are defined as “Not Applicable".